StemGen, Inc.
SGNI
$0.10
$0.06150.00%
| 03/31/2022 | 12/31/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -67.19% | -- | |||
| Gross Profit | -158.33% | -- | |||
| SG&A Expenses | 420.49% | -62.60% | |||
| Depreciation & Amortization | -3.72% | 3.87% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 184.63% | -36.38% | |||
| Operating Income | -325.19% | 57.41% | |||
| Income Before Tax | -128.26% | 40.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -128.26% | 40.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -128.26% | 40.15% | |||
| EBIT | -325.19% | 57.41% | |||
| EBITDA | -613.43% | 71.95% | |||
| EPS Basic | -127.78% | 40.00% | |||
| Normalized Basic EPS | -163.64% | 42.11% | |||
| EPS Diluted | -127.78% | 40.00% | |||
| Normalized Diluted EPS | -163.64% | 42.11% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
